CACCURI, Francesca
 Distribuzione geografica
Continente #
NA - Nord America 6.191
AS - Asia 2.723
EU - Europa 2.370
SA - Sud America 613
AF - Africa 67
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.983
Nazione #
US - Stati Uniti d'America 6.084
SG - Singapore 1.001
CN - Cina 818
IT - Italia 576
BR - Brasile 529
HK - Hong Kong 408
UA - Ucraina 398
DE - Germania 291
PL - Polonia 264
FI - Finlandia 202
VN - Vietnam 141
GB - Regno Unito 140
TR - Turchia 119
RU - Federazione Russa 117
FR - Francia 94
IE - Irlanda 92
IN - India 56
CA - Canada 46
MX - Messico 40
SE - Svezia 40
AR - Argentina 38
BD - Bangladesh 34
BE - Belgio 28
ID - Indonesia 25
CZ - Repubblica Ceca 22
ZA - Sudafrica 22
AT - Austria 21
IQ - Iraq 21
JP - Giappone 21
ES - Italia 19
NL - Olanda 16
UZ - Uzbekistan 13
AU - Australia 12
EC - Ecuador 12
LT - Lituania 10
MA - Marocco 10
PK - Pakistan 9
VE - Venezuela 9
JO - Giordania 8
ET - Etiopia 7
CO - Colombia 6
EG - Egitto 6
EU - Europa 6
KE - Kenya 6
NO - Norvegia 6
AZ - Azerbaigian 5
CL - Cile 5
CR - Costa Rica 5
IR - Iran 5
KG - Kirghizistan 5
PE - Perù 5
PT - Portogallo 5
UY - Uruguay 5
CH - Svizzera 4
IL - Israele 4
KZ - Kazakistan 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
JM - Giamaica 3
KR - Corea 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
MU - Mauritius 3
OM - Oman 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BG - Bulgaria 2
BY - Bielorussia 2
CM - Camerun 2
DK - Danimarca 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
PR - Porto Rico 2
RO - Romania 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
GT - Guatemala 1
HU - Ungheria 1
IM - Isola di Man 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RE - Reunion 1
SL - Sierra Leone 1
Totale 11.980
Città #
Fairfield 717
Ashburn 545
Woodbridge 504
Singapore 444
Hong Kong 407
Seattle 352
Houston 317
Cambridge 299
Jacksonville 288
Ann Arbor 270
Warsaw 260
Chandler 255
Wilmington 240
Dallas 225
Beijing 218
Brescia 207
New York 181
Princeton 167
Helsinki 137
Los Angeles 133
Istanbul 100
Dublin 92
Munich 78
The Dalles 73
Shanghai 66
Dearborn 62
Nanjing 61
Redondo Beach 51
São Paulo 51
Chicago 50
Ho Chi Minh City 49
San Francisco 49
Des Moines 45
Buffalo 42
Moscow 36
San Diego 35
Hanoi 33
Hebei 31
Turku 30
Nanchang 29
Brussels 27
Changsha 27
Boardman 26
London 26
Jinan 24
Milan 23
Nuremberg 22
Shenyang 22
Brno 20
Brooklyn 20
Stockholm 20
Tianjin 20
Santa Clara 19
Mexico City 18
Tokyo 18
Boston 17
Charlotte 17
Rome 17
Toronto 17
Johannesburg 16
Phoenix 16
Guangzhou 15
Jiaxing 15
Rio de Janeiro 15
Orem 14
Belo Horizonte 13
Denver 13
Manchester 13
Montreal 13
Curitiba 12
Dong Ket 12
Tashkent 12
Atlanta 11
Romola 11
Zhengzhou 11
Chennai 10
Frankfurt am Main 10
Salt Lake City 10
Taizhou 10
Kocaeli 9
Kunming 9
Ningbo 9
Verona 9
Baghdad 8
Falkenstein 8
Haikou 8
Kilburn 8
Lallio 8
Poplar 8
Porto Alegre 8
Amman 7
Amsterdam 7
Auburn Hills 7
Brasília 7
Castiglione Delle Stiviere 7
Falls Church 7
Ottawa 7
Porto 7
Redwood City 7
Vienna 7
Totale 8.043
Nome #
U94 of human herpesvirus 6 down-modulates Src, promotes a partial mesenchymal-to-epithelial transition and inhibits tumor cell growth, invasion and metastasis 322
Detection and molecular characterization of enteric viruses in children with acute gastroenteritis in Northern Italy 245
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 202
A cluster of invasive listeriosis in Brescia, Italy. 197
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 191
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 188
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 182
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 177
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 175
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 172
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 172
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 171
In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae. 167
Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17. 164
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 159
Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition 157
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 155
Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient 155
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 154
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 153
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 148
Myroides odoratimimus urinary tract infection in an immunocompromised patient: An emerging multidrug-resistant micro-organism 147
Analysis of mutations in DNA gyrase and topoisomerase IV of Ureaplasma urealyticum and Ureaplasma parvum serovars resistant to fluoroquinolones 146
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 145
Targeting p35/Cdk5 signalling via CIP-peptide promotes angiogenesis in hypoxia. 145
Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth. 144
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 144
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 144
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 144
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 142
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 141
HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders 139
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 134
Extensively drug-resistant Acinetobacter baumannii isolated from intensive care units in Northern Italy: a genomic approach to characterize new sequence types. 134
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 134
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 133
HIV-1 matrix protein p17 and its receptors. 131
HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness 131
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 131
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 130
Inhibition of dna repair mechanisms and induction of apoptosis in triple negative breast cancer cells expressing the human herpesvirus 6 u94 130
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 125
Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis. 125
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 125
Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study 124
Serological Response to SARS-CoV-2 in Health Care Workers Employed in a Large Tertiary Hospital in Lombardy, Northern Italy 123
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 123
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 122
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 119
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation 119
Fulminant septic shock caused by Capnocytophaga canimorsus in Italy: Case report 119
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 118
Clinical course of chronic hepatitis B patients receiving nucleos(t)ide analogues after virological breakthrough during monotherapy with lamivudine. 114
Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae" 114
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 113
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 112
A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine 112
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants 111
Programmable Nucleic Acid Nanoswitches for the Rapid, Single-Step Detection of Antibodies in Bodily Fluids 109
Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120 106
A topical desiccant agent in association with ultrasonic debridement in the initial treatment of chronic periodontitis: a clinical and microbiological study 106
null 104
Human Herpesvirus 6A and 6B inhibit in vitro angiogenesis by induction of Human Leukocyte Antigen G 103
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 100
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 97
Presence of V72I, G123S and R127K Integrase Inhibitor polymorphisms could reduce ART effectiveness: a retrospective longitudinal study 97
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 97
HIV-1 infection, microenvironment and endothelial cell dysfunction. 95
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 93
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 92
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 90
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 88
Role of Q675H mutation in improving SARS-CoV-2 spike interaction with the furin binding pocket 88
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 87
The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy 87
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 84
Genomic surveillance of SARS-CoV-2 in patients presenting neurological manifestations 81
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 80
Serosurvey in BNT162b2 vaccine-elicited neutralizing antibodies against authentic B.1, B.1.1.7, B.1.351, B.1.525 and P.1 SARS-CoV-2 variants 78
Design and Validation of Broad-Spectrum Antiviral Compounds Against SARS-CoV-2 78
Traceability of SARS-CoV-2 transmission through quasispecies analysis 75
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 74
Doxycycline inhibition of a pseudotyped virus transduction does not translate to inhibition of sars-cov-2 infectivity 72
Peptide-Antibody Fusions Engineered by Phage Display Exhibit an Ultrapotent and Broad Neutralization of SARS-CoV-2 Variants 71
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 70
THE ROLE OF GLYCOSAMINOGLYCANS IN SPIKE SARS-CoV-2 INFECTION: FROM A MODEL FOR HEPARAN SULFATES TO A STARTING STRUCTURE FOR ANTIVIRALS 67
Detection of SARS-CoV-2 Alpha variant in a severely immunocompromised HIV-1-infected patient in the omicron era 66
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 65
The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier 63
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 62
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 62
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 60
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 59
Ultrapotent and broad neutralization of SARS-CoV-2 variants by modular, tetravalent, bi-paratopic antibodies 58
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 58
A Rare Case of Multidrug-resistant Leclercia adecarboxylata Catheter-related Bloodstream Infection and an Updated Brief Literature Review 57
Viral proteins as emerging cancer therapeutics 55
The role of heparin in spike SARS-COV-2 infection: From a model for heparan sulfates to a starting structure for antivirals 54
Covid-19 ocular prophylaxis: The potential role of ozonated-oils in liposome eyedrop gel 48
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 48
Totale 11.877
Categoria #
all - tutte 62.442
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.442


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.056 0 0 0 0 0 132 155 238 123 192 147 69
2021/2022845 71 129 9 47 17 34 45 83 32 94 63 221
2022/2023839 121 11 28 54 77 199 4 107 142 2 52 42
2023/2024895 61 18 75 65 46 141 50 43 184 26 46 140
2024/20252.127 32 14 22 284 156 195 207 103 202 191 444 277
2025/20262.704 442 622 474 584 471 111 0 0 0 0 0 0
Totale 12.283